{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:04:08Z","timestamp":1791299048184,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T00:00:00Z","timestamp":1542067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000770","name":"University of Manchester","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000770","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11912-018-0747-1","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T23:13:41Z","timestamp":1542064421000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Prevention Strategies in Endometrial Carcinoma"],"prefix":"10.1007","volume":"20","author":[{"given":"Michelle L.","family":"MacKintosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma J.","family":"Crosbie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,13]]},"reference":[{"key":"747_CR1","first-page":"151","volume":"8","author":"AL Beavis","year":"2016","unstructured":"Beavis AL, Smith AJB, Fader AN. Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management. Int J Womens Health. 2016;8:151\u201367.","journal-title":"Int J Womens Health"},{"issue":"9809","key":"747_CR2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","volume":"378","author":"J Burn","year":"2011","unstructured":"Burn J, Gerdes A-M, Macrae F, Mecklin J-P, Moeslein G, Olschwang S, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet Lond Engl. 2011;378(9809):2081\u20137.","journal-title":"Lancet Lond Engl"},{"issue":"7","key":"747_CR3","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/1471-0528.12106","volume":"120","author":"M MacKintosh","year":"2013","unstructured":"MacKintosh M, Crosbie E. Obesity-driven endometrial cancer: is weight loss the answer? BJOG Int J Obstet Gynaecol. 2013 Jun;120(7):791\u20134.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"747_CR4","unstructured":"Statistics on obesity, physical activity and diet: England, 2012. [cited 2012 Nov 7]. Available from: \n                      http:\/\/www.ic.nhs.uk\/statistics-and-data-collections\/health-and-lifestyles\/obesity\/statistics-on-obesity-physical-activity-and-diet-england-2012\n                      \n                    ."},{"issue":"1","key":"747_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jmig.2015.08.007","volume":"23","author":"S Uccella","year":"2016","unstructured":"Uccella S, Bonzini M, Palomba S, Fanfani F, Ceccaroni M, Seracchioli R, et al. Impact of obesity on surgical treatment for endometrial cancer: a multicenter study comparing laparoscopy vs open surgery, with propensity-matched analysis. J Minim Invasive Gynecol. 2016 Jan;23(1):53\u201361.","journal-title":"J Minim Invasive Gynecol"},{"issue":"12","key":"747_CR6","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1001\/jamaoncol.2017.0619","volume":"3","author":"NAJ Ryan","year":"2017","unstructured":"Ryan NAJ, Morris J, Green K, Lalloo F, Woodward ER, Hill J, et al. Association of mismatch repair mutation with age at cancer onset in Lynch syndrome: implications for stratified surveillance strategies. JAMA Oncol. 2017;3(12):1702\u20136.","journal-title":"JAMA Oncol"},{"issue":"1","key":"747_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ygyno.2016.03.007","volume":"141","author":"LM Randall","year":"2016","unstructured":"Randall LM, Pothuri B. The genetic prediction of risk for gynecologic cancers. Gynecol Oncol. 2016;141(1):10\u20136.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"747_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1056\/NEJMoa052627","volume":"354","author":"KM Schmeler","year":"2006","unstructured":"Schmeler KM, Lynch HT, Chen L, Munsell MF, Soliman PT, Clark MB, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med. 2006;354(3):261\u20139.","journal-title":"N Engl J Med"},{"key":"747_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejogrb.2017.04.015","volume":"213","author":"S Sundar","year":"2017","unstructured":"Sundar S, Balega J, Crosbie E, Drake A, Edmondson R, Fotopoulou C, et al. BGCS uterine cancer guidelines: recommendations for practice. Eur J Obstet Gynecol Reprod Biol. 2017;213:71\u201397.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"747_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1600-0412.2011.01091.x","volume":"90","author":"A Auranen","year":"2011","unstructured":"Auranen A, Joutsiniemi T. A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families. Acta Obstet Gynecol Scand. 2011;90(5):437\u201344.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"747_CR11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ygyno.2017.01.005","volume":"144","author":"NAJ Ryan","year":"2017","unstructured":"Ryan NAJ, Evans DG, Green K, Crosbie EJ. Pathological features and clinical behavior of Lynch syndrome-associated ovarian cancer. Gynecol Oncol. 2017;144(3):491\u20135.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"747_CR12","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1158\/1940-6207.CAPR-13-0020","volume":"6","author":"KH Lu","year":"2013","unstructured":"Lu KH, Loose DS, Yates MS, Nogueras-Gonzalez GM, Munsell MF, Chen L-M, et al. Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome. Cancer Prev Res (Phila). 2013;6(8):774\u201381.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"4","key":"747_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s12325-018-0683-3","volume":"35","author":"G Funston","year":"2018","unstructured":"Funston G, O\u2019Flynn H, Ryan NAJ, Hamilton W, Crosbie EJ. Recognizing gynecological cancer in primary care: risk factors, red flags, and referrals. Adv Ther. 2018;35(4):577\u201389.","journal-title":"Adv Ther"},{"issue":"5","key":"747_CR14","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1097\/AOG.0b013e31828bf80c","volume":"121","author":"AWY Wong","year":"2013","unstructured":"Wong AWY, Chan SSC, Yeo W, Yu M-Y, Tam W-H. Prophylactic use of levonorgestrel-releasing intrauterine system in women with breast cancer treated with tamoxifen: a randomized controlled trial. Obstet Gynecol. 2013;121(5):943\u201350.","journal-title":"Obstet Gynecol"},{"issue":"Suppl 1","key":"747_CR15","doi-asserted-by":"publisher","first-page":"S429","DOI":"10.1016\/j.dsx.2017.03.030","volume":"11","author":"Z Faghfoori","year":"2017","unstructured":"Faghfoori Z, Fazelian S, Shadnoush M, Goodarzi R. Nutritional management in women with polycystic ovary syndrome: a review study. Diabetes Metab Syndr. 2017;11(Suppl 1):S429\u201332.","journal-title":"Diabetes Metab Syndr"},{"issue":"2","key":"747_CR16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/annonc\/mdv539","volume":"27","author":"A Mitsuhashi","year":"2016","unstructured":"Mitsuhashi A, Sato Y, Kiyokawa T, Koshizaka M, Hanaoka H, Shozu M. Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer. Ann Oncol Off J Eur Soc Med Oncol. 2016;27(2):262\u20136.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"1","key":"747_CR17","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ygyno.2013.10.028","volume":"132","author":"MN Shafiee","year":"2014","unstructured":"Shafiee MN, Khan G, Ariffin R, Abu J, Chapman C, Deen S, et al. Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help? Gynecol Oncol. 2014;132(1):248\u201353.","journal-title":"Gynecol Oncol"},{"key":"747_CR18","volume-title":"Food, nutrition, physical activity, and the prevention of cancer: a global perspective","author":"WCRF\/AICR","year":"2007","unstructured":"WCRF\/AICR. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR; 2007."},{"issue":"6","key":"747_CR19","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/humupd\/dmu037","volume":"20","author":"VN Sivalingam","year":"2014","unstructured":"Sivalingam VN, Myers J, Nicholas S, Balen AH, Crosbie EJ. Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications. Hum Reprod Update. 2014;20(6):853\u201368.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"747_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/1471-0528.13731","volume":"123","author":"AG Renehan","year":"2016","unstructured":"Renehan AG, MacKintosh ML, Crosbie EJ. Obesity and endometrial cancer: unanswered epidemiological questions. BJOG Int J Obstet Gynaecol. 2016;123(2):175\u20138.","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"12","key":"747_CR21","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1158\/1055-9965.EPI-10-0832","volume":"19","author":"E Crosbie","year":"2010","unstructured":"Crosbie E, Zwahlen M, Kitchener H, Egger M, Renehan A. Body mass index, hormone replacement therapy and endometrial cancer risk: a meta analysis. Cancer Epidemiol Biomark Prev. 2010;19(12):3119\u201330.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"747_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jama.281.3.235","volume":"281","author":"MH Davidson","year":"1999","unstructured":"Davidson MH, Hauptman J, DiGirolamo M, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA. 1999;281(3):235\u201342.","journal-title":"JAMA"},{"issue":"2","key":"747_CR23","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/archinternmed.2009.508","volume":"170","author":"DH Ryan","year":"2010","unstructured":"Ryan DH, Johnson WD, Myers VH, Prather TL, McGlone MM, Rood J, et al. Nonsurgical weight loss for extreme obesity in primary care settings: results of the Louisiana Obese Subjects Study. Arch Intern Med. 2010;170(2):146\u201354.","journal-title":"Arch Intern Med"},{"issue":"1","key":"747_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ygyno.2013.11.012","volume":"133","author":"KK Ward","year":"2014","unstructured":"Ward KK, Roncancio AM, Shah NR, Davis M-A, Saenz CC, McHale MT, et al. Bariatric surgery decreases the risk of uterine malignancy. Gynecol Oncol. 2014;133(1):63\u20136.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"747_CR25","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ygyno.2017.02.036","volume":"145","author":"A Anveden","year":"2017","unstructured":"\u2022 Anveden A, Taube M, Peltonen M, Jacobson P, Andersson-Assarsson JC, Sjoholm K, et al. Long-term incidence of female-specific cancer after bariatric surgery or usual care in the Swedish Obese Subjects Study. Gynecol Oncol. 2017;145(2):224\u20139 Prospective non-randomised study with 18-year follow-up demonstrating a significant reduction in risk of endometrial cancer after bariatric surgery HR 0.56; 95% CI 0.35\u20130.89, p\u2009=\u20090.014.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"747_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10552-013-0333-7","volume":"25","author":"VL Stevens","year":"2014","unstructured":"Stevens VL, Jacobs EJ, Patel AV, Sun J, Gapstur SM, McCullough ML. Body weight in early adulthood, adult weight gain, and risk of endometrial cancer in women not using postmenopausal hormones. Cancer Causes Control. 2014;25(3):321\u20138.","journal-title":"Cancer Causes Control"},{"issue":"5","key":"747_CR27","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1158\/1055-9965.EPI-16-0611","volume":"26","author":"LM Welti","year":"2017","unstructured":"\u2022 Welti LM, Beavers DP, Caan BJ, Sangi-Haghpeykar H, Vitolins MZ, Beavers KM. Weight fluctuation and cancer risk in postmenopausal women: the women\u2019s health initiative. Cancer Epidemiol Biomarkers Prev. 2017;26(5):779\u201386 Data from the WHI Observational Study of 80,943 women (788 cases of endometrial cancer) demonstrated that both weight gain and weight cycling increase endometrial cancer risk (weight cycling HR 1.23, 95% CI 1.01\u20131.49).","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"747_CR28","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41416-018-0240-5","volume":"11","author":"M Silva da","year":"2018","unstructured":"da Silva M, Weiderpass E, Licaj I, Lissner L, Rylander C. Excess body weight, weight gain and obesity-related cancer risk in women in Norway: the Norwegian Women and Cancer study. Br J Cancer. 2018;11:646\u201356.","journal-title":"Br J Cancer"},{"issue":"8","key":"747_CR29","doi-asserted-by":"publisher","first-page":"e1002081","DOI":"10.1371\/journal.pmed.1002081","volume":"13","author":"M Arnold","year":"2016","unstructured":"Arnold M, Jiang L, Stefanick ML, Johnson KC, Lane DS, LeBlanc ES, et al. Duration of adulthood overweight, obesity, and cancer risk in the Women\u2019s Health Initiative: a longitudinal study from the United States. PLoS Med. 2016;13(8):e1002081.","journal-title":"PLoS Med"},{"issue":"7","key":"747_CR30","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/ijo.2016.56","volume":"40","author":"J Aarestrup","year":"2005","unstructured":"Aarestrup J, Gamborg M, Ulrich LG, Sorensen TIA, Baker JL. Childhood body mass index and height and risk of histologic subtypes of endometrial cancer. Int J Obes. 2005;40(7):1096\u2013102.","journal-title":"Int J Obes"},{"issue":"5","key":"747_CR31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10654-015-0017-6","volume":"30","author":"D Schmid","year":"2015","unstructured":"Schmid D, Behrens G, Keimling M, Jochem C, Ricci C, Leitzmann M. A systematic review and meta-analysis of physical activity and endometrial cancer risk. Eur J Epidemiol. 2015;30(5):397\u2013412.","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"747_CR32","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1001\/jamainternmed.2016.1548","volume":"176","author":"SC Moore","year":"2016","unstructured":"\u2022 Moore SC, Lee I-M, Weiderpass E, Campbell PT, Sampson JN, Kitahara CM, et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern Med. 2016;176(6):816\u201325 Pooled data from 12 European and US cohorts (1.44 million participants, 5346 cases of endometrial cancer) found a significant inverse association between cancer risk and activity levels in women who were overweight or obese, when adjusted for BMI.","journal-title":"JAMA Intern Med"},{"issue":"6","key":"747_CR33","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10552-018-1032-1","volume":"29","author":"R Arthur","year":"2018","unstructured":"\u2022 Arthur R, Kirsh VA, Kreiger N, Rohan T. A healthy lifestyle index and its association with risk of breast, endometrial, and ovarian cancer among Canadian women. Cancer Causes Control. 2018;29(6):485\u201393 This study used a Healthy Lifestyle Index to assess the association of modifiable risk factors with endometrial cancer risk, in 177 cases of endometrial cancer from the Canadian Study of Diet, Lifestyle and Health. Each unit increase in Healthy Lifestyle Index was associated with a 5% reduction in endometrial cancer risk (HR 0.95; 95% CI 0.90\u20130.99).","journal-title":"Cancer Causes Control"},{"issue":"7","key":"747_CR34","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s00125-007-0681-5","volume":"50","author":"E Friberg","year":"2007","unstructured":"Friberg E, Orsini N, Montzoros C, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007;50(7):1365\u201374.","journal-title":"Diabetologia"},{"key":"747_CR35","doi-asserted-by":"publisher","first-page":"g7607","DOI":"10.1136\/bmj.g7607","volume":"350","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JPA. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607.","journal-title":"BMJ"},{"key":"747_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.diabres.2018.03.002","volume":"143","author":"C Sacerdote","year":"2018","unstructured":"Sacerdote C, Ricceri F. Epidemiological dimensions of the association between type 2 diabetes and cancer: a review of observational studies. Diabetes Res Clin Pract. 2018;143:369\u201377.","journal-title":"Diabetes Res Clin Pract"},{"key":"747_CR37","unstructured":"Kitson S, Crosbie E. Hormonal and metabolic strategies to overcome insulin resistance and prevent endometrial Cancer. In: Berger NA et al, editors. Focus on Gynecologic Malignancies, Energy Balance and Cancer."},{"issue":"3","key":"747_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/bjc.2015.453","volume":"114","author":"VN Sivalingam","year":"2016","unstructured":"Sivalingam VN, Kitson S, McVey R, Roberts C, Pemberton P, Gilmour K, et al. Measuring the biological effect of presurgical metformin treatment in endometrial cancer. Br J Cancer. 2016 Feb 2;114(3):281\u20139.","journal-title":"Br J Cancer"},{"issue":"8","key":"747_CR39","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1158\/1940-6207.CAPR-17-0398","volume":"11","author":"MS Yates","year":"2018","unstructured":"Yates MS, Coletta AM, Zhang Q, Schmandt RE, Medepalli M, Nebgen D, et al. Prospective randomized biomarker study of metformin and lifestyle intervention for prevention in obese women at increased risk for endometrial cancer. Cancer Prev Res (Phila). 2018;11(8):477\u201390.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"747_CR40","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12885-018-4334-5","volume":"18","author":"D Chu","year":"2018","unstructured":"Chu D, Wu J, Wang K, Zhao M, Wang C, Li L, et al. Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis. BMC Cancer. 2018;18(1):438.","journal-title":"BMC Cancer"},{"issue":"6","key":"747_CR41","doi-asserted-by":"publisher","first-page":"580.e1","DOI":"10.1016\/j.ajog.2017.02.002","volume":"216","author":"L Iversen","year":"2017","unstructured":"\u2022 Iversen L, Sivasubramaniam S, Lee AJ, Fielding S, Hannaford PC. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners\u2019 Oral Contraception Study. Am J Obstet Gynecol. 2017;216(6):580.e1\u20139 Long-term follow-up data from a prospective observational study showing that ever-use of COC has a protective effect against cancers, including endometrial (incidence rate 0.66, 99% CI 0.48\u20130.89) that persists for at least 30\u00a0years.","journal-title":"Am J Obstet Gynecol"},{"key":"747_CR42","unstructured":"Faculty of Sexual & Reproductive Healthcare. The UK Medical Eligibility Criteria for Contraceptive Use. Royal College of Obstetricians & Gynaecologists; 2009."},{"issue":"1","key":"747_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ygyno.2018.02.006","volume":"149","author":"M Jareid","year":"2018","unstructured":"\u2022 Jareid M, Thalabard J-C, Aarflot M, Bovelstad HM, Lund E, Braaten T. Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study. Gynecol Oncol. 2018;149(1):127\u201332 Population-based prospective cohort study of women in the Norwegian Women and Cancer Study, showing ever-use of LNG-IUS reduced the risk of endometrial cancer (RR 0.22, 95% CI 0.13-0.40) compared with never-use.","journal-title":"Gynecol Oncol"},{"key":"747_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.maturitas.2016.05.013","volume":"91","author":"LL Sjogren","year":"2016","unstructured":"Sjogren LL, Morch LS, Lokkegaard E. Hormone replacement therapy and the risk of endometrial cancer: a systematic review. Maturitas. 2016;91:25\u201335.","journal-title":"Maturitas"},{"issue":"3","key":"747_CR45","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1080\/00325481.2017.1281083","volume":"129","author":"SJ Parish","year":"2017","unstructured":"\u2022 Parish SJ, Gillespie JA. The evolving role of oral hormonal therapies and review of conjugated estrogens\/bazedoxifene for the management of menopausal symptoms. Postgrad Med. 2017;129(3):340\u201351 First review article detailing the potential of conjugated oestrogen\/bazedoxifene for menopausal HRT for non-hysterectomised women, which may be useful in women who cannot take progestagens.","journal-title":"Postgrad Med"},{"issue":"10","key":"747_CR46","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/pds.4075","volume":"25","author":"Y-J Ou","year":"2016","unstructured":"\u2022 Ou Y-J, Chiu H-F, Wong Y-H, Yang Y-H. Bisphosphonate use and the risk of endometrial cancer: a meta-analysis of observational studies. Pharmacoepidemiol Drug Saf. 2016;25(10):1107\u201315 Meta-analysis of cohort and case control studies demonstrating a statistically significant reduction in endometrial cancer risk with bisphosphonate use, which increases with greater duration of treatment (3\u00a0years pooled RR 0.44; 95% CI 0.28\u20130.70).","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"747_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.294.1.47","volume":"294","author":"NR Cook","year":"2005","unstructured":"Cook NR, Lee I-M, Gaziano JM, Gordon D, Ridker PM, Manson JE, et al. Low-dose aspirin in the primary prevention of cancer: the Women\u2019s Health Study: a randomized controlled trial. JAMA. 2005;294(1):47\u201355.","journal-title":"JAMA"},{"issue":"2","key":"747_CR48","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ygyno.2015.12.009","volume":"140","author":"F Verdoodt","year":"2016","unstructured":"Verdoodt F, Friis S, Dehlendorff C, Albieri V, Kjaer SK. Non-steroidal anti-inflammatory drug use and risk of endometrial cancer: a systematic review and meta-analysis of observational studies. Gynecol Oncol. 2016;140(2):352\u20138.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"747_CR49","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12885-018-4156-5","volume":"18","author":"Y Qiao","year":"2018","unstructured":"Qiao Y, Yang T, Gan Y, Li W, Wang C, Gong Y, et al. Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies. BMC Cancer. 2018;18(1):288.","journal-title":"BMC Cancer"},{"issue":"4","key":"747_CR50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1158\/1940-6207.CAPR-17-0026","volume":"10","author":"VC Jordan","year":"2017","unstructured":"Jordan VC. The 4Ps of breast cancer chemoprevention: putting proven principles into practice. Cancer Prev Res (Phila). 2017;10(4):219\u201322.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5","key":"747_CR51","doi-asserted-by":"publisher","first-page":"E410","DOI":"10.1002\/ijc.29229","volume":"136","author":"AS Felix","year":"2015","unstructured":"Felix AS, Gaudet MM, La Vecchia C, Nagle CM, Shu XO, Weiderpass E, et al. Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium. Int J Cancer. 2015;136(5):E410\u201322.","journal-title":"Int J Cancer"},{"issue":"4","key":"747_CR52","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jand.2016.09.036","volume":"118","author":"X-S Zhong","year":"2018","unstructured":"Zhong X-S, Ge J, Chen S-W, Xiong Y-Q, Ma S-J, Chen Q. Association between dietary isoflavones in soy and legumes and endometrial cancer: a systematic review and meta-analysis. J Acad Nutr Diet. 2018;118(4):637\u201351.","journal-title":"J Acad Nutr Diet"},{"issue":"3","key":"747_CR53","first-page":"784","volume":"10","author":"KM Malloy","year":"2018","unstructured":"Malloy KM, Wang J, Clark LH, Fang Z, Sun W, Yin Y, et al. Novasoy and genistein inhibit endometrial cancer cell proliferation through disruption of the AKT\/mTOR and MAPK signaling pathways. Am J Transl Res. 2018;10(3):784\u201395.","journal-title":"Am J Transl Res"},{"key":"747_CR54","doi-asserted-by":"publisher","first-page":"13410","DOI":"10.1038\/srep13410","volume":"5","author":"Q Zhou","year":"2015","unstructured":"\u2022 Zhou Q, Luo M-L, Li H, Li M, Zhou J-G. Coffee consumption and risk of endometrial cancer: a dose-response meta-analysis of prospective cohort studies. Sci Rep. 2015;5:13410 A meta-analysis of over 1.5 million participants and 10,100 endometrial cancer cases confirmed a dose-dependent endometrial cancer risk with coffee intake, which was greater but not limited to caffeinated coffee.","journal-title":"Sci Rep"},{"issue":"2","key":"747_CR55","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1158\/1055-9965.EPI-14-0970","volume":"24","author":"MA Merritt","year":"2015","unstructured":"Merritt MA, Tzoulaki I, Tworoger SS, De Vivo I, Hankinson SE, Fernandes J, et al. Investigation of dietary factors and endometrial cancer risk using a nutrient-wide association study approach in the EPIC and Nurses\u2019 Health Study (NHS) and NHSII. Cancer Epidemiol Biomarkers Prev. 2015;24(2):466\u201371.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"747_CR56","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ajog.2008.10.032","volume":"200","author":"F Bravi","year":"2009","unstructured":"Bravi F, Scotti L, Bosetti C, Gallus S, Negri E, La Vecchia C, et al. Coffee drinking and endometrial cancer risk: a metaanalysis of observational studies. Am J Obstet Gynecol. 2009;200(2):130\u20135.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"747_CR57","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ygyno.2016.08.333","volume":"143","author":"YL Wan","year":"2016","unstructured":"Wan YL, Beverley-Stevenson R, Carlisle D, Clarke S, Edmondson RJ, Glover S, et al. Working together to shape the endometrial cancer research agenda: the top ten unanswered research questions. Gynecol Oncol. 2016;143(2):287\u201393.","journal-title":"Gynecol Oncol"},{"key":"747_CR58","doi-asserted-by":"crossref","unstructured":"MacKintosh M, Derbyshire A, McVey R, Bolton J, Nickkho-Amiry M, Higgins C, et al. The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk. Int J Cancer. 2018;In press.","DOI":"10.1002\/ijc.31913"},{"issue":"1","key":"747_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/1940-6207.CAPR-16-0224","volume":"10","author":"SJ Kitson","year":"2017","unstructured":"Kitson SJ, Evans DG, Crosbie EJ. Identifying high-risk women for endometrial cancer prevention strategies: proposal of an endometrial cancer risk prediction model. Cancer Prev Res (Phila). 2017;10(1):1\u201313.","journal-title":"Cancer Prev Res (Phila)"},{"key":"747_CR60","doi-asserted-by":"crossref","unstructured":"Kitson S, Ryan N, MacKintosh ML, Edmondson R, Duffy JM, Crosbie EJ. Interventions for weight reduction in obesity to improve survival in women with endometrial cancer. Cochrane Database Syst Rev. 2018 [cited 2018 Oct 1]; Available from: \n                      https:\/\/www.readcube.com\/articles\/10.1002\/14651858.CD012513.pub2\n                      \n                    .","DOI":"10.1002\/14651858.CD012513.pub2"},{"key":"747_CR61","doi-asserted-by":"crossref","unstructured":"Kitson SJ, Lindsay J, Sivalingam VN, Rutter MK, Crosbie EJ. High prevalence of metabolic syndrome in women newly diagnosed with endometrial cancer. Gynecol Oncol Rep. 2018 Aug 23 [cited 2018 Oct 1]; Available from: \n                      http:\/\/www.sciencedirect.com\/science\/article\/pii\/S2352578918300808\n                      \n                    .","DOI":"10.1016\/j.gore.2018.08.006"},{"issue":"1","key":"747_CR62","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ygyno.2017.11.019","volume":"148","author":"SJ Kitson","year":"2018","unstructured":"Kitson SJ, Lindsay J, Sivalingam VN, Lunt M, Ryan NAJ, Edmondson RJ, et al. The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: a prospective case control study. Gynecol Oncol. 2018;148(1):154\u201360.","journal-title":"Gynecol Oncol"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-018-0747-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-018-0747-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-018-0747-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T12:56:33Z","timestamp":1576500993000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-018-0747-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,13]]},"references-count":62,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["747"],"URL":"https:\/\/doi.org\/10.1007\/s11912-018-0747-1","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,13]]},"assertion":[{"value":"13 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Michelle L. MacKintosh declares that she has no conflict of interest. Emma J. Crosbie is supported by a grant from the NIHR Manchester Biomedical Research Centre.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"101"}}